These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 37212320)

  • 1. Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection.
    Fong SW; Goh YS; Torres-Ruesta A; Chang ZW; Chan YH; Neo VK; Lee B; Duan K; Amrun SN; Yeo NK; Chen HV; Tay MZ; Carissimo G; ; ; Tan SY; Leo YS; Lye DC; Renia L; Young BE; Ng LFP
    J Med Virol; 2023 May; 95(5):e28774. PubMed ID: 37212320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
    Hu Z; van der Ploeg K; Chakraborty S; Arunachalam PS; Mori DAM; Jacobson KB; Bonilla H; Parsonnet J; Andrews JR; Holubar M; Subramanian A; Khosla C; Maldonado Y; Hedlin H; de la Parte L; Press K; Ty M; Tan GS; Blish C; Takahashi S; Rodriguez-Barraquer I; Greenhouse B; Butte AJ; Singh U; Pulendran B; Wang TT; Jagannathan P
    Elife; 2022 Oct; 11():. PubMed ID: 36239699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients.
    Berezhnoy G; Bissinger R; Liu A; Cannet C; Schäfer H; Kienzle K; Bitzer M; Häberle H; Göpel S; Trautwein C; Singh Y
    Front Immunol; 2023; 14():1144224. PubMed ID: 37228606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic phenotype of patients with long-COVID syndrome of 1-year duration.
    García-Abellán J; Fernández M; Padilla S; García JA; Agulló V; Lozano V; Ena N; García-Sánchez L; Gutiérrez F; Masiá M
    Front Immunol; 2022; 13():920627. PubMed ID: 36090973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
    Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
    Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
    Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC
    Front Immunol; 2023; 14():1182182. PubMed ID: 37868959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study.
    Fjelltveit EB; Blomberg B; Kuwelker K; Zhou F; Onyango TB; Brokstad KA; Elyanow R; Kaplan IM; Tøndel C; Mohn KGI; Özgümüş T; Cox RJ; Langeland N;
    Clin Infect Dis; 2023 Feb; 76(3):e60-e70. PubMed ID: 35959897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up.
    Mazza MG; Palladini M; De Lorenzo R; Magnaghi C; Poletti S; Furlan R; Ciceri F; ; Rovere-Querini P; Benedetti F
    Brain Behav Immun; 2021 May; 94():138-147. PubMed ID: 33639239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls.
    Sandmann FG; Tessier E; Lacy J; Kall M; Van Leeuwen E; Charlett A; Eggo RM; Dabrera G; Edmunds WJ; Ramsay M; Campbell H; Amirthalingam G; Jit M
    Clin Infect Dis; 2022 Aug; 75(1):e962-e973. PubMed ID: 35245941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections.
    Kennedy AE; Cook L; Breznik JA; Cowbrough B; Wallace JG; Huynh A; Smith JW; Son K; Stacey H; Ang J; McGeer A; Coleman BL; Larché M; Larché M; Hambly N; Nair P; Ask K; Miller MS; Bramson J; Levings MK; Nazy I; Svenningsen S; Mukherjee M; Bowdish DME
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.